EyePoint, Inc.

EYPTSEC EDGAR

Laboratory Analytical Instruments(DE)CIK: 1314102

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$43.3M	$46.0M	$41.4M	$36.9M	$34.4M
Research and Development Expense	$132.9M	$64.7M	$49.6M	$28.5M	$17.4M
Operating Expenses	$189.1M	$121.1M	$141.0M	$92.2M	$71.7M
Operating Income (Loss)	-$145.9M	-$75.1M	-$99.6M	-$55.3M	-$37.3M
Interest Expense	—	—	$3.2M	$5.5M	$7.3M
Nonoperating Income (Expense)	$15.1M	$4.4M	-$2.6M	-$3.1M	-$8.1M
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$130.8M	-$70.7M	-$102.3M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$418.5M	$355.2M	$180.4M	$263.4M	$91.7M
Assets, Current	$383.3M	$344.8M	$172.8M	$237.7M	$63.1M
Cash and Cash Equivalents, at Carrying Value	$99.7M	$281.3M	$95.6M	$178.6M	$44.9M
Inventory, Net	$2.3M	$3.9M	$2.9M	$3.6M	$5.3M
Liabilities	$82.0M	$88.9M	$84.0M	$79.0M	$73.2M
Liabilities, Current	$49.0M	$63.3M	$34.5M	$23.7M	$14.9M
Long-term Debt	—	—	—	$30.0M	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$126.2M	$1.9M	-$65.0M	-$50.1M	-$14.4M
Net Cash Provided by (Used in) Investing Activities	-$219.4M	-$3.3M	-$17.3M	-$33.1M	-$362.0K
Net Cash Provided by (Used in) Financing Activities	$164.0M	$187.1M	-$690.0K	$216.9M	$37.5M
Payments to Acquire Property, Plant, and Equipment	$4.1M	$3.5M	$2.1M	$156.0K	$362.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)